{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Nortopixantrone",
  "nciThesaurus": {
    "casRegistry": "156090-17-4",
    "chebiId": "",
    "chemicalFormula": "C20H24N6O2",
    "definition": "A 9-aza-anthrapyrazole-based antineoplastic antibiotic. Nortopixantrone intercalates into DNA, induces single- and double-stranded DNA breaks and inhibits topoisomerase II, thereby inhibiting DNA replication and repair as well as RNA and protein synthesis. Nortopixantrone is less cardiotoxicity than anthracyclines.",
    "fdaUniiCode": "PH2639TAB4",
    "identifier": "C81423",
    "preferredName": "Nortopixantrone",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C2107"
    ],
    "synonyms": [
      "NORTOPIXANTRONE",
      "Nortopixantrone"
    ]
  }
}